Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
Guidance Documents/Guidance-Document/FDA Oversight of PET Drug Products -- Questions and Answers

FDA Oversight of PET Drug Products -- Questions and Answers

Detailed guidance document from FDA and regulatory agencies.

Document Details

Guidance Document

December 3, 2012

April 10, 2019

Center for Drug Evaluation and Research

3e894e01-dc7a-4e5e-a828-a0b032a0404f

Related Documents

ANDAs: Stability Testing of Drug Substances and Products, Questions and Answers

Guidance DocumentMay 15, 2014Center for Drug Evaluation and Research
View Details →

Investigational New Drug Applications for Positron Emission Tomography (PET) Drugs

Guidance DocumentDecember 3, 2012Center for Drug Evaluation and Research
View Details →

PET Drug Products - Current Good Manufacturing Practice (CGMP)

Guidance DocumentDecember 10, 2009Center for Drug Evaluation and Research
View Details →

Quick Actions

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Transform Regulatory Data into Actionable Intelligence

Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.

KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.